drugset / Trial / NCT05730062

Influence of Oxycodone on Individuals Taking an SSRI

NCT05730062

Phase 1 Unknown 55 enrolled Leiden University Medical Center
RandomizedCrossoverTriple-blindBasic science

Summary

This study will determine whether selective serotonin reuptake inhibitors (SSRI) exacerbate opioid induced respiratory depression in patients initiating treatment for underlying conditions such as depression or an anxiety disorder. Next to paroxetine which has been evaluated in a previous study in healthy volunteers sertraline, citalopram and escitalopram will be evaluated with regards to its influence on opioid induced respiratory depression.

Timeline

Start
2023-03-15
Primary completion
2025-01-15
Completion
2025-04-15

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Oxycodone Other / unclassified 10 mg